The role of the preventive cardiologist in addressing climate change

The role of the preventive cardiologist in addressing climate change

Bibliographic Details
Main Author:	Martha Gulati
Format:	Article
Language:	English
Published:	Elsevier 2022-09-01
Series:	American Journal of Preventive Cardiology
Subjects:	Atherosclerotic cardiovascular disease Climate change Prevention Pollution
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666667722000599

Similar Items

Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors
by: Saket Girotra, et al.
Published: (2023-10-01)

Statin Use and Eligibility for Primary Prevention of Atherosclerotic Cardiovascular Disease Among Adults at Borderline or Intermediate Risk in the United States
by: Michael M. Hammond, et al.
Published: (2023-04-01)

Association between 5-year change in cardiovascular risk and the incidence of atherosclerotic cardiovascular diseases: a multi-cohort study
by: Jiayi Yi, et al.
Published: (2023-09-01)

Moving toward combination lipid-lowering therapy for all patients with atherosclerotic cardiovascular disease
by: Kamil F. Faridi, et al.
Published: (2023-06-01)

Association between Cardiovascular Disease and Liver Disease, from a Clinically Pragmatic Perspective as a Cardiologist
by: Mitsutaka Nakashima, et al.
Published: (2023-02-01)

Monoclonal Antibodies, Gene Silencing and Gene Editing (CRISPR) Therapies for the Treatment of Hyperlipidemia—The Future Is Here
by: Melody Hermel, et al.
Published: (2023-01-01)

Holistic Approach in Follow-up of Individuals Living with HIV: Primary Cardiovascular Protection
by: Nursel ÇALIK BAŞARAN, et al.
Published: (2024-03-01)

Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum
by: Michael J. Wilkinson, et al.
Published: (2023-06-01)

Cardiovascular Disease Prevention in Patients With Atherosclerotic Renovascular Disease‐Induced Resistant Hypertension: Further Considerations for 24‐Hour Blood Pressure Profiles
by: Keisuke Narita, et al.
Published: (2022-09-01)

Earlier treatment in adults with high lifetime risk of cardiovascular diseases: What prevention trials are feasible and could change clinical practice? Report of a National Heart, Lung, and Blood Institute (NHLBI) Workshop
by: Ann Marie Navar, et al.
Published: (2022-12-01)

Do statins benefit low-risk population for primary prevention of atherosclerotic cardiovascular disease: A retrospective cohort study
by: In Sun Ryou, et al.
Published: (2022-11-01)

A telehealth-delivered intervention to extend the veteran HIV treatment cascade for cardiovascular disease prevention: V-EXTRA-CVD study protocol for a randomized controlled trial
by: Lewis Musoke, et al.
Published: (2023-12-01)

Clinical Evaluation of Patients with Genetically Confirmed Familial Hypercholesterolemia
by: Andrea Aparicio, et al.
Published: (2023-01-01)

High‐Intensity Statin Reduces the Risk of Mortality Among Chronic Liver Disease Patients With Atherosclerotic Cardiovascular Disease: A Population‐Based Cohort Study
by: Sungho Bea, et al.
Published: (2023-04-01)

PREVENTING PERIPHERAL ARTERIAL DISEASE: THE CRUCIAL ROLE OF CARDIOLOGISTS.
by: Abilesh Kumar
Published: (2023-12-01)

The Noordwijk, declaration on climatic change
by: Ministerial Conference on Atmospheric Pollution and Climatic Change (1989: Noordwijk, Netherlands)
Published: (1989)

The effect of telemedicine on secondary prevention of atherosclerotic cardiovascular disease: A systematic review and meta-analysis
by: Liangying Deng, et al.
Published: (2022-11-01)

The Value of Subclinical Carotid Atherosclerosis for Primary Prevention of Cardiovascular Diseases. Review of the Main International Studies
by: E. K. Butina, et al.
Published: (2016-11-01)

Pregnancy History at 40 Years of Age as a Marker of Cardiovascular Risk
by: Liv G. Kvalvik, et al.
Published: (2024-03-01)

Factors Associated With Enhanced Low‐Density Lipoprotein Cholesterol Lowering With Bempedoic Acid
by: Christie M. Ballantyne, et al.
Published: (2022-08-01)

Fibrinogen and Atherosclerotic Cardiovascular Diseases—Review of the Literature and Clinical Studies
by: Stanisław Surma, et al.
Published: (2021-12-01)

Natural language processing to identify reasons for sex disparity in statin prescriptions
by: Celeste Witting, et al.
Published: (2023-06-01)

Focus on Prevention: Peripheral Arterial Disease and the Central Role of the Cardiologist
by: Vincenzo Fioretti, et al.
Published: (2023-06-01)

Mitochondrial Heteroplasmy as a Marker for Premature Coronary Artery Disease: Analysis of the Poly-C Tract of the Control Region Sequence
by: Rebeca Lorca, et al.
Published: (2023-03-01)

Higher Cholesterol Absorption Marker at Baseline Predicts Fewer Cardiovascular Events in Elderly Patients Receiving Hypercholesterolemia Treatment: The KEEP Study
by: Masanari Kuwabara, et al.
Published: (2024-02-01)

Greenhouse governance : addressing climate change in America /
by: Rabe, Barry George, 1957-
Published: (2010)

Climate Change and Cardiovascular Health
by: William W. Aitken, et al.
Published: (2022-12-01)

The Impact of Climate Change and Extreme Weather Conditions on Cardiovascular Health and Acute Cardiovascular Diseases
by: Antonio De Vita, et al.
Published: (2024-01-01)

Research Landscape on Atherosclerotic Cardiovascular Disease and Inflammation: A Bibliometric and Visualized Study
by: Wende Tian, et al.
Published: (2022-09-01)

The Impact of Age on Statin-Related Glycemia: A Propensity Score-Matched Cohort Study in Korea
by: Shaopeng Xu, et al.
Published: (2022-04-01)

A novel cuproptosis-related diagnostic gene signature and differential expression validation in atherosclerosis
by: Yuting Cui, et al.
Published: (2023-07-01)

2022 focused update of the 2017 Taiwan lipid guidelines for high risk patients: Coronary artery disease, peripheral artery disease and ischemic stroke
by: Po-Sheng Chen, et al.
Published: (2022-08-01)

10-YEAR RISK ESTIMATION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN HYPERTENSIVE PATIENTS
by: Olha M. Chernatska, et al.
Published: (2021-06-01)

Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease
by: Guillaume Marquis‐Gravel, et al.
Published: (2024-02-01)

Health effects of climate change in Africa: A call for an improved implementation of prevention measures
by: Enos Moyo, et al.
Published: (2023-06-01)

The mediation effect of lipids, blood pressure and BMI between air pollutant mixture and atherosclerotic cardiovascular disease: The CHCN-BTH cohort study
by: Bingxiao Li, et al.
Published: (2023-10-01)

Change of Heart: The Underexplored Role of Plaque Hemorrhage in the Evaluation of Stroke of Undetermined Etiology
by: David R. Holmes, et al.
Published: (2022-05-01)

Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues
by: M. V. Zhuravleva, et al.
Published: (2020-09-01)

Exploring linkages: addressing the relationship between the climate crisis and HIV prevention with recommendations for emerging pre-exposure prophylaxis programs
by: Katie M. Williams, et al.
Published: (2024-03-01)

Addressing climate change mitigation: Implications for the sustainable alternatives to plastics
by: Sung Hee Joo
Published: (2024-01-01)